Evaluation of the efficacy and safety of plasma exeresis in periorbital rejuvenation using the Reviscometer®.
J Cosmet Dermatol
; 21(6): 2550-2558, 2022 Jun.
Article
em En
| MEDLINE
| ID: mdl-34520602
ABSTRACT
BACKGROUND:
Periorbital rejuvenation is performed through various methods. Recently, plasma exeresis has been suggested for the treatment of dermatochalasis and periorbital wrinkles.AIMS:
To evaluate the clinical efficacy and safety of plasma exeresis in periorbital rejuvenation and palpebral laxity and assess its effectiveness using the Reviscometer® . PATIENTS/METHODS:
Fifty-six women with mild-to-severe dermatochalasis and periorbital wrinkles volunteered to participate in this clinical trial. They received plasma exeresis thrice at one-month intervals. The efficacy of the intervention was evaluated according to the Cutaneous Resonance Running Time (CRRT) value changes, photographic changes, patients' satisfaction, and clinical side effects.RESULTS:
This study showed significant clinical improvements in dermatochalasis and palpebral laxity after treatment compared with the baseline (p < 0.001). Most of the participants had relative satisfaction, and no significant or permanent side effects were observed.CONCLUSION:
The findings of this study suggest that plasma exeresis is a safe and effective nonsurgical method for periorbital rejuvenation. Furthermore, the procedure has no serious adverse effects if performed correctly and for the right patient.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Rejuvenescimento
/
Envelhecimento da Pele
Limite:
Female
/
Humans
Idioma:
En
Revista:
J Cosmet Dermatol
Ano de publicação:
2022
Tipo de documento:
Article